100
Participants
Start Date
July 31, 2024
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
a novel short regimen
An intensive phase consisting of isoniazid, bedaquiline, moxifloxacin and pyrazinamide for 2 months (9 weeks). A continuation phase consisting of isoniazid, bedaquiline, and levofloxacin for 4 months (17 weeks). Treatment may be extended for 3 months (13 weeks) in patients with severe disease or with delayed culture conversion, defined by culture positive at 4 months of treatment.
Hualien Tzu Chi General Hospital
OTHER
Chest Hospital, Ministry of Health and Welfare, Taiwan
OTHER_GOV
Chang-Hua Hospital
OTHER_GOV
Taichung Veterans General Hospital
OTHER
Taichung Hospital, Ministry of Health and Welfare
UNKNOWN
Taoyuan General Hospital
OTHER_GOV
Kaohsiung Veterans General Hospital.
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Taipei Medical University WanFang Hospital
OTHER